SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-003017
Filing Date
2021-02-09
Accepted
2021-02-09 08:00:11
Documents
14
Period of Report
2021-02-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35900
2 ex99-1.htm EX-99.1 13669
3 ex99-1_001.jpg GRAPHIC 8440
  Complete submission text file 0001493152-21-003017.txt   243255

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE hrow-20210209.xsd EX-101.SCH 3190
5 XBRL LABEL FILE hrow-20210209_lab.xml EX-101.LAB 35274
6 XBRL PRESENTATION FILE hrow-20210209_pre.xml EX-101.PRE 23149
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3780
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 21603964
SIC: 2834 Pharmaceutical Preparations